The global Flurbiprofen market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Flurbiprofen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Flurbiprofen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Flurbiprofen in Nonsteroidal Anti-Inflammatory Drugs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Flurbiprofen include Teva, Mylan Pharmaceuticals, Tokuhon, Recordati, Mikasa Seiyaku, Bausch Health, Pfizer, AbbVie and Abbott, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Flurbiprofen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flurbiprofen.

Report Scope

The Flurbiprofen market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flurbiprofen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Flurbiprofen companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Flurbiprofen Market Report

Report Metric	Details
Report Name	Flurbiprofen Market
Segment by Type	Injection Patch Tablet
Segment by Application	Nonsteroidal Anti-Inflammatory Drugs Topical Administration for Joint And Muscle Pain Soft Tissue Disease Dysmenorrhea Post-Operative Pain Toothache Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva, Mylan Pharmaceuticals, Tokuhon, Recordati, Mikasa Seiyaku, Bausch Health, Pfizer, AbbVie, Abbott, Allergan, Pharma-Logic, Kaken Pharma, Mitsubishi Tanab, Sun Pharma, Aa Pharma, Pro Doc Limitee, PD-Rx Pharmaceuticals, Beijing Taide Pharmaceutical, Wuhan Daan Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flurbiprofen companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Flurbiprofen Market report?

Ans: The main players in the Flurbiprofen Market are Teva, Mylan Pharmaceuticals, Tokuhon, Recordati, Mikasa Seiyaku, Bausch Health, Pfizer, AbbVie, Abbott, Allergan, Pharma-Logic, Kaken Pharma, Mitsubishi Tanab, Sun Pharma, Aa Pharma, Pro Doc Limitee, PD-Rx Pharmaceuticals, Beijing Taide Pharmaceutical, Wuhan Daan Pharmaceutical

What are the Application segmentation covered in the Flurbiprofen Market report?

Ans: The Applications covered in the Flurbiprofen Market report are Nonsteroidal Anti-Inflammatory Drugs, Topical Administration for Joint And Muscle Pain, Soft Tissue Disease, Dysmenorrhea, Post-Operative Pain, Toothache, Other

What are the Type segmentation covered in the Flurbiprofen Market report?

Ans: The Types covered in the Flurbiprofen Market report are Injection, Patch, Tablet

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Flurbiprofen Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Injection

1.2.3 Patch

1.2.4 Tablet

1.3 Market by Application

1.3.1 Global Flurbiprofen Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Nonsteroidal Anti-Inflammatory Drugs

1.3.3 Topical Administration for Joint And Muscle Pain

1.3.4 Soft Tissue Disease

1.3.5 Dysmenorrhea

1.3.6 Post-Operative Pain

1.3.7 Toothache

1.3.8 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Flurbiprofen Market Perspective (2019-2030)

2.2 Flurbiprofen Growth Trends by Region

2.2.1 Global Flurbiprofen Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Flurbiprofen Historic Market Size by Region (2019-2024)

2.2.3 Flurbiprofen Forecasted Market Size by Region (2025-2030)

2.3 Flurbiprofen Market Dynamics

2.3.1 Flurbiprofen Industry Trends

2.3.2 Flurbiprofen Market Drivers

2.3.3 Flurbiprofen Market Challenges

2.3.4 Flurbiprofen Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Flurbiprofen Players by Revenue

3.1.1 Global Top Flurbiprofen Players by Revenue (2019-2024)

3.1.2 Global Flurbiprofen Revenue Market Share by Players (2019-2024)

3.2 Global Flurbiprofen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Flurbiprofen Revenue

3.4 Global Flurbiprofen Market Concentration Ratio

3.4.1 Global Flurbiprofen Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Flurbiprofen Revenue in 2023

3.5 Flurbiprofen Key Players Head office and Area Served

3.6 Key Players Flurbiprofen Product Solution and Service

3.7 Date of Enter into Flurbiprofen Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Flurbiprofen Breakdown Data by Type

4.1 Global Flurbiprofen Historic Market Size by Type (2019-2024)

4.2 Global Flurbiprofen Forecasted Market Size by Type (2025-2030)

5 Flurbiprofen Breakdown Data by Application

5.1 Global Flurbiprofen Historic Market Size by Application (2019-2024)

5.2 Global Flurbiprofen Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Flurbiprofen Market Size (2019-2030)

6.2 North America Flurbiprofen Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Flurbiprofen Market Size by Country (2019-2024)

6.4 North America Flurbiprofen Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Flurbiprofen Market Size (2019-2030)

7.2 Europe Flurbiprofen Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Flurbiprofen Market Size by Country (2019-2024)

7.4 Europe Flurbiprofen Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Flurbiprofen Market Size (2019-2030)

8.2 Asia-Pacific Flurbiprofen Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Flurbiprofen Market Size by Region (2019-2024)

8.4 Asia-Pacific Flurbiprofen Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Flurbiprofen Market Size (2019-2030)

9.2 Latin America Flurbiprofen Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Flurbiprofen Market Size by Country (2019-2024)

9.4 Latin America Flurbiprofen Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Flurbiprofen Market Size (2019-2030)

10.2 Middle East & Africa Flurbiprofen Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Flurbiprofen Market Size by Country (2019-2024)

10.4 Middle East & Africa Flurbiprofen Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Teva

11.1.1 Teva Company Detail

11.1.2 Teva Business Overview

11.1.3 Teva Flurbiprofen Introduction

11.1.4 Teva Revenue in Flurbiprofen Business (2019-2024)

11.1.5 Teva Recent Development

11.2 Mylan Pharmaceuticals

11.2.1 Mylan Pharmaceuticals Company Detail

11.2.2 Mylan Pharmaceuticals Business Overview

11.2.3 Mylan Pharmaceuticals Flurbiprofen Introduction

11.2.4 Mylan Pharmaceuticals Revenue in Flurbiprofen Business (2019-2024)

11.2.5 Mylan Pharmaceuticals Recent Development

11.3 Tokuhon

11.3.1 Tokuhon Company Detail

11.3.2 Tokuhon Business Overview

11.3.3 Tokuhon Flurbiprofen Introduction

11.3.4 Tokuhon Revenue in Flurbiprofen Business (2019-2024)

11.3.5 Tokuhon Recent Development

11.4 Recordati

11.4.1 Recordati Company Detail

11.4.2 Recordati Business Overview

11.4.3 Recordati Flurbiprofen Introduction

11.4.4 Recordati Revenue in Flurbiprofen Business (2019-2024)

11.4.5 Recordati Recent Development

11.5 Mikasa Seiyaku

11.5.1 Mikasa Seiyaku Company Detail

11.5.2 Mikasa Seiyaku Business Overview

11.5.3 Mikasa Seiyaku Flurbiprofen Introduction

11.5.4 Mikasa Seiyaku Revenue in Flurbiprofen Business (2019-2024)

11.5.5 Mikasa Seiyaku Recent Development

11.6 Bausch Health

11.6.1 Bausch Health Company Detail

11.6.2 Bausch Health Business Overview

11.6.3 Bausch Health Flurbiprofen Introduction

11.6.4 Bausch Health Revenue in Flurbiprofen Business (2019-2024)

11.6.5 Bausch Health Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Detail

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Flurbiprofen Introduction

11.7.4 Pfizer Revenue in Flurbiprofen Business (2019-2024)

11.7.5 Pfizer Recent Development

11.8 AbbVie

11.8.1 AbbVie Company Detail

11.8.2 AbbVie Business Overview

11.8.3 AbbVie Flurbiprofen Introduction

11.8.4 AbbVie Revenue in Flurbiprofen Business (2019-2024)

11.8.5 AbbVie Recent Development

11.9 Abbott

11.9.1 Abbott Company Detail

11.9.2 Abbott Business Overview

11.9.3 Abbott Flurbiprofen Introduction

11.9.4 Abbott Revenue in Flurbiprofen Business (2019-2024)

11.9.5 Abbott Recent Development

11.10 Allergan

11.10.1 Allergan Company Detail

11.10.2 Allergan Business Overview

11.10.3 Allergan Flurbiprofen Introduction

11.10.4 Allergan Revenue in Flurbiprofen Business (2019-2024)

11.10.5 Allergan Recent Development

11.11 Pharma-Logic

11.11.1 Pharma-Logic Company Detail

11.11.2 Pharma-Logic Business Overview

11.11.3 Pharma-Logic Flurbiprofen Introduction

11.11.4 Pharma-Logic Revenue in Flurbiprofen Business (2019-2024)

11.11.5 Pharma-Logic Recent Development

11.12 Kaken Pharma

11.12.1 Kaken Pharma Company Detail

11.12.2 Kaken Pharma Business Overview

11.12.3 Kaken Pharma Flurbiprofen Introduction

11.12.4 Kaken Pharma Revenue in Flurbiprofen Business (2019-2024)

11.12.5 Kaken Pharma Recent Development

11.13 Mitsubishi Tanab

11.13.1 Mitsubishi Tanab Company Detail

11.13.2 Mitsubishi Tanab Business Overview

11.13.3 Mitsubishi Tanab Flurbiprofen Introduction

11.13.4 Mitsubishi Tanab Revenue in Flurbiprofen Business (2019-2024)

11.13.5 Mitsubishi Tanab Recent Development

11.14 Sun Pharma

11.14.1 Sun Pharma Company Detail

11.14.2 Sun Pharma Business Overview

11.14.3 Sun Pharma Flurbiprofen Introduction

11.14.4 Sun Pharma Revenue in Flurbiprofen Business (2019-2024)

11.14.5 Sun Pharma Recent Development

11.15 Aa Pharma

11.15.1 Aa Pharma Company Detail

11.15.2 Aa Pharma Business Overview

11.15.3 Aa Pharma Flurbiprofen Introduction

11.15.4 Aa Pharma Revenue in Flurbiprofen Business (2019-2024)

11.15.5 Aa Pharma Recent Development

11.16 Pro Doc Limitee

11.16.1 Pro Doc Limitee Company Detail

11.16.2 Pro Doc Limitee Business Overview

11.16.3 Pro Doc Limitee Flurbiprofen Introduction

11.16.4 Pro Doc Limitee Revenue in Flurbiprofen Business (2019-2024)

11.16.5 Pro Doc Limitee Recent Development

11.17 PD-Rx Pharmaceuticals

11.17.1 PD-Rx Pharmaceuticals Company Detail

11.17.2 PD-Rx Pharmaceuticals Business Overview

11.17.3 PD-Rx Pharmaceuticals Flurbiprofen Introduction

11.17.4 PD-Rx Pharmaceuticals Revenue in Flurbiprofen Business (2019-2024)

11.17.5 PD-Rx Pharmaceuticals Recent Development

11.18 Beijing Taide Pharmaceutical

11.18.1 Beijing Taide Pharmaceutical Company Detail

11.18.2 Beijing Taide Pharmaceutical Business Overview

11.18.3 Beijing Taide Pharmaceutical Flurbiprofen Introduction

11.18.4 Beijing Taide Pharmaceutical Revenue in Flurbiprofen Business (2019-2024)

11.18.5 Beijing Taide Pharmaceutical Recent Development

11.19 Wuhan Daan Pharmaceutical

11.19.1 Wuhan Daan Pharmaceutical Company Detail

11.19.2 Wuhan Daan Pharmaceutical Business Overview

11.19.3 Wuhan Daan Pharmaceutical Flurbiprofen Introduction

11.19.4 Wuhan Daan Pharmaceutical Revenue in Flurbiprofen Business (2019-2024)

11.19.5 Wuhan Daan Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

TEVA

Mylan Pharmaceuticals

PD-Rx Pharmaceuticals

Beijing Taide Pharmaceutical

Wuhan Daan Pharmaceutical

List of Tables

Table 1. Global Flurbiprofen Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Injection

Table 3. Key Players of Patch

Table 4. Key Players of Tablet

Table 5. Global Flurbiprofen Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Flurbiprofen Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Flurbiprofen Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Flurbiprofen Market Share by Region (2019-2024)

Table 9. Global Flurbiprofen Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Flurbiprofen Market Share by Region (2025-2030)

Table 11. Flurbiprofen Market Trends

Table 12. Flurbiprofen Market Drivers

Table 13. Flurbiprofen Market Challenges

Table 14. Flurbiprofen Market Restraints

Table 15. Global Flurbiprofen Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Flurbiprofen Market Share by Players (2019-2024)

Table 17. Global Top Flurbiprofen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flurbiprofen as of 2023)

Table 18. Ranking of Global Top Flurbiprofen Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Flurbiprofen Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Flurbiprofen Product Solution and Service

Table 22. Date of Enter into Flurbiprofen Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Flurbiprofen Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Flurbiprofen Revenue Market Share by Type (2019-2024)

Table 26. Global Flurbiprofen Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Flurbiprofen Revenue Market Share by Type (2025-2030)

Table 28. Global Flurbiprofen Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Flurbiprofen Revenue Market Share by Application (2019-2024)

Table 30. Global Flurbiprofen Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Flurbiprofen Revenue Market Share by Application (2025-2030)

Table 32. North America Flurbiprofen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Flurbiprofen Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Flurbiprofen Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Flurbiprofen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Flurbiprofen Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Flurbiprofen Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Flurbiprofen Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Flurbiprofen Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Flurbiprofen Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Flurbiprofen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Flurbiprofen Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Flurbiprofen Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Flurbiprofen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Flurbiprofen Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Flurbiprofen Market Size by Country (2025-2030) & (US$ Million)

Table 47. Teva Company Detail

Table 48. Teva Business Overview

Table 49. Teva Flurbiprofen Product

Table 50. Teva Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 51. Teva Recent Development

Table 52. Mylan Pharmaceuticals Company Detail

Table 53. Mylan Pharmaceuticals Business Overview

Table 54. Mylan Pharmaceuticals Flurbiprofen Product

Table 55. Mylan Pharmaceuticals Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 56. Mylan Pharmaceuticals Recent Development

Table 57. Tokuhon Company Detail

Table 58. Tokuhon Business Overview

Table 59. Tokuhon Flurbiprofen Product

Table 60. Tokuhon Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 61. Tokuhon Recent Development

Table 62. Recordati Company Detail

Table 63. Recordati Business Overview

Table 64. Recordati Flurbiprofen Product

Table 65. Recordati Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 66. Recordati Recent Development

Table 67. Mikasa Seiyaku Company Detail

Table 68. Mikasa Seiyaku Business Overview

Table 69. Mikasa Seiyaku Flurbiprofen Product

Table 70. Mikasa Seiyaku Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 71. Mikasa Seiyaku Recent Development

Table 72. Bausch Health Company Detail

Table 73. Bausch Health Business Overview

Table 74. Bausch Health Flurbiprofen Product

Table 75. Bausch Health Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 76. Bausch Health Recent Development

Table 77. Pfizer Company Detail

Table 78. Pfizer Business Overview

Table 79. Pfizer Flurbiprofen Product

Table 80. Pfizer Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 81. Pfizer Recent Development

Table 82. AbbVie Company Detail

Table 83. AbbVie Business Overview

Table 84. AbbVie Flurbiprofen Product

Table 85. AbbVie Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 86. AbbVie Recent Development

Table 87. Abbott Company Detail

Table 88. Abbott Business Overview

Table 89. Abbott Flurbiprofen Product

Table 90. Abbott Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 91. Abbott Recent Development

Table 92. Allergan Company Detail

Table 93. Allergan Business Overview

Table 94. Allergan Flurbiprofen Product

Table 95. Allergan Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 96. Allergan Recent Development

Table 97. Pharma-Logic Company Detail

Table 98. Pharma-Logic Business Overview

Table 99. Pharma-Logic Flurbiprofen Product

Table 100. Pharma-Logic Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 101. Pharma-Logic Recent Development

Table 102. Kaken Pharma Company Detail

Table 103. Kaken Pharma Business Overview

Table 104. Kaken Pharma Flurbiprofen Product

Table 105. Kaken Pharma Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 106. Kaken Pharma Recent Development

Table 107. Mitsubishi Tanab Company Detail

Table 108. Mitsubishi Tanab Business Overview

Table 109. Mitsubishi Tanab Flurbiprofen Product

Table 110. Mitsubishi Tanab Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 111. Mitsubishi Tanab Recent Development

Table 112. Sun Pharma Company Detail

Table 113. Sun Pharma Business Overview

Table 114. Sun Pharma Flurbiprofen Product

Table 115. Sun Pharma Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 116. Sun Pharma Recent Development

Table 117. Aa Pharma Company Detail

Table 118. Aa Pharma Business Overview

Table 119. Aa Pharma Flurbiprofen Product

Table 120. Aa Pharma Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 121. Aa Pharma Recent Development

Table 122. Pro Doc Limitee Company Detail

Table 123. Pro Doc Limitee Business Overview

Table 124. Pro Doc Limitee Flurbiprofen Product

Table 125. Pro Doc Limitee Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 126. Pro Doc Limitee Recent Development

Table 127. PD-Rx Pharmaceuticals Company Detail

Table 128. PD-Rx Pharmaceuticals Business Overview

Table 129. PD-Rx Pharmaceuticals Flurbiprofen Product

Table 130. PD-Rx Pharmaceuticals Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 131. PD-Rx Pharmaceuticals Recent Development

Table 132. Beijing Taide Pharmaceutical Company Detail

Table 133. Beijing Taide Pharmaceutical Business Overview

Table 134. Beijing Taide Pharmaceutical Flurbiprofen Product

Table 135. Beijing Taide Pharmaceutical Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 136. Beijing Taide Pharmaceutical Recent Development

Table 137. Wuhan Daan Pharmaceutical Company Detail

Table 138. Wuhan Daan Pharmaceutical Business Overview

Table 139. Wuhan Daan Pharmaceutical Flurbiprofen Product

Table 140. Wuhan Daan Pharmaceutical Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)

Table 141. Wuhan Daan Pharmaceutical Recent Development

Table 142. Research Programs/Design for This Report

Table 143. Key Data Information from Secondary Sources

Table 144. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Flurbiprofen Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Flurbiprofen Market Share by Type: 2023 VS 2030

Figure 3. Injection Features

Figure 4. Patch Features

Figure 5. Tablet Features

Figure 6. Global Flurbiprofen Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Flurbiprofen Market Share by Application: 2023 VS 2030

Figure 8. Nonsteroidal Anti-Inflammatory Drugs Case Studies

Figure 9. Topical Administration for Joint And Muscle Pain Case Studies

Figure 10. Soft Tissue Disease Case Studies

Figure 11. Dysmenorrhea Case Studies

Figure 12. Post-Operative Pain Case Studies

Figure 13. Toothache Case Studies

Figure 14. Other Case Studies

Figure 15. Flurbiprofen Report Years Considered

Figure 16. Global Flurbiprofen Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Flurbiprofen Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Flurbiprofen Market Share by Region: 2023 VS 2030

Figure 19. Global Flurbiprofen Market Share by Players in 2023

Figure 20. Global Top Flurbiprofen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flurbiprofen as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Flurbiprofen Revenue in 2023

Figure 22. North America Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Flurbiprofen Market Share by Country (2019-2030)

Figure 24. United States Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Flurbiprofen Market Share by Country (2019-2030)

Figure 28. Germany Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Flurbiprofen Market Share by Region (2019-2030)

Figure 36. China Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Japan Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. South Korea Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. India Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Australia Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Flurbiprofen Market Share by Country (2019-2030)

Figure 44. Mexico Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Brazil Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Flurbiprofen Market Share by Country (2019-2030)

Figure 48. Turkey Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Teva Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 51. Mylan Pharmaceuticals Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 52. Tokuhon Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 53. Recordati Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 54. Mikasa Seiyaku Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 55. Bausch Health Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 56. Pfizer Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 57. AbbVie Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 58. Abbott Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 59. Allergan Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 60. Pharma-Logic Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 61. Kaken Pharma Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 62. Mitsubishi Tanab Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 63. Sun Pharma Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 64. Aa Pharma Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 65. Pro Doc Limitee Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 66. PD-Rx Pharmaceuticals Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 67. Beijing Taide Pharmaceutical Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 68. Wuhan Daan Pharmaceutical Revenue Growth Rate in Flurbiprofen Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Flutriafol Market Research Report 2025

Global Fluralaner Market Research Report 2025

Global Flucycloxuron Market Research Report 2025

Global Fluticasone Market Research Report 2024

Global Regorafenib Market Research Report 2024

Global Naproxen Tablets Market Research Report 2024

Global Pirfenidone Market Research Report 2024

Global Flumethrin Market Research Report 2025

Global Loxoprofen Sodium Tablets Market Research Report 2024

Global Flumetralin Market Research Report 2025

Global Afidopyropen Market Research Report 2024

Global Niraparib Market Research Report 2024

Global Olaparib Market Research Report 2024

Global Regorafenib Tablets Market Research Report 2024

Global Flumioxazin Market Research Report 2025

Global Indobufen API Market Research Report 2025

Global Perflubron Market Research Report 2025

Global Rifabutin Market Research Report 2024

Global Urapidil Market Research Report 2024

RELATED REPORTS

Global Residential Aged Care Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20P19635

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Nitric Oxide Therapy System Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-13G13075

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Fractional Flow Reserve Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-39F2213

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Assisted Living Franchise Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8U19550

Thu Jun 05 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions